<-- HI/society/cost-effectiveness-quality-life-laparoscopic-ileocecal-resection-versus-infliximab-active-terminal-ileitis-crohns-disease-randomized-controlled-trial/--> AIS CHANNEL - The ultimate surgical training experience! //
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
Cost-effectiveness and Quality of Life of Laparoscopic Ileocecal Resection Versus Infliximab of Active Terminal Ileitis in Crohn’s Disease: a Randomized Controlled Trial
Posted in Lectures on 1 February 2018

Willem Bemelman
Department of Gastroenterology and Surgery
Academic Medical Center, Amsterdam, The Netherlands